GPCR vs GNTX Comparison

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue was about 89% of total revenue in 2025, down from 98% in 2024 due to the Voxx acquisition in April 2025. The company is constantly developing new applications for the technology to remain on top. Sales in 2025 totaled about $2.5 billion with 44.8 million mirrors shipped. The unit mix breaks out as 64% interior and 36% exterior versus 31% exterior in 2019. The company is based in Zeeland, Michigan.